Roivant Sciences Ltd. ROIV
38.73 USD +0.02 (+0.05%)
Regular-session close
38.73 0.00 0.00%
After hours · Nov 18, 4:54 PM ET
38.29 Day range 39.24
19.96 52-week range 42.50
- YTD
- +78.48%
- 1 year
- +88.74%
News
benzinga.com David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes DME Capital Management reveals its new third-quarter stock picks. Here's what David Einhorn has been buying.
seekingalpha.com Roivant Sciences Ltd. (ROIV) Presents at Jefferies Global Healthcare Conference 2026 Transcript Roivant Sciences Ltd. (ROIV) Presents at Jefferies Global Healthcare Conference 2026 Transcriptbenzinga.com Guggenheim Maintains Buy on Roivant Sciences, Raises Price Target to $48 Guggenheim analyst Yatin Suneja maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $46 to $48.
seekingalpha.com Don't Fight The Momentum: Roivant Has Big Expectations, But Real Pipeline Momentum Roivant Sciences Ltd. remains a Buy as its diversified "-vant" model delivers multiple blockbuster pipeline opportunities and robust cash reserves. Immunovant's IMVT-1402 shows superior efficacy in…
benzinga.com Nvidia To $300? Here Are 10 Top Analyst Forecasts For Tuesday Analysts adjusted targets: RIOT upgraded to Buy; WIX downgraded to Underperform; targets also changed for MNDY, ONTO, ROIV, FERG and NVDA.benzinga.com HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $48 HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $47 to $48.
benzinga.com Roivant Sciences Q2 2027 Earnings Call Transcript Roivant Sciences (NASDAQ:ROIV) reported second-quarter financial results on Monday. The transcript from the company’s second-quarter earnings call has been provided below.This transcript is brought…
benzinga.com KKR, Constellation Energy On Deck Monday As Private Credit, Power Face Test KKR headlines Monday’s reports, with investors weighing whether fundraising momentum can offset a sharp year-to-date stock decline. Constellation Energy, Barrick Mining, Ferguson Enterprises and ORIX…
benzinga.com Here’s How Much You Would Have Made Owning Roivant Sciences Stock In The Last 5 Years Roivant Sciences (NASDAQ:ROIV) has outperformed the market over the past 5 years by 26.08% on an annualized basis producing an average annual return of 35.57%. Currently, Roivant Sciences has a…benzinga.com Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $56 Citigroup analyst Samantha Semenkow maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $46 to $56.
benzinga.com If You Invested $100 In Roivant Sciences Stock 5 Years Ago, You Would Have This Much Today Roivant Sciences (NASDAQ:ROIV) has outperformed the market over the past 5 years by 26.86% on an annualized basis producing an average annual return of 37.68%. Currently, Roivant Sciences has a…
benzinga.com Why Is Roivant Sciences Stock Surging Wednesday? Roivant (ROIV) shares jump as Phase 3 CLARITY trials show brepocitinib effectively treats noninfectious uveitis & reduces steroid reliance.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion. CalciMedica (NASDAQ:CALC)…
